Zynex EBITDA Margin 2010-2025 | ZYXI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Zynex (ZYXI) over the last 10 years. The current EBITDA margin for Zynex as of March 31, 2025 is .
| Zynex EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.17B | $0.00B | -1.73% |
| 2024-12-31 | $0.19B | $0.01B | 5.70% |
| 2024-09-30 | $0.19B | $0.01B | 6.70% |
| 2024-06-30 | $0.19B | $0.02B | 7.73% |
| 2024-03-31 | $0.19B | $0.02B | 8.47% |
| 2023-12-31 | $0.18B | $0.02B | 8.15% |
| 2023-09-30 | $0.19B | $0.02B | 12.37% |
| 2023-06-30 | $0.18B | $0.02B | 12.92% |
| 2023-03-31 | $0.17B | $0.02B | 14.12% |
| 2022-12-31 | $0.16B | $0.03B | 16.35% |
| 2022-09-30 | $0.15B | $0.03B | 18.00% |
| 2022-06-30 | $0.14B | $0.03B | 20.28% |
| 2022-03-31 | $0.14B | $0.03B | 20.44% |
| 2021-12-31 | $0.13B | $0.02B | 18.46% |
| 2021-09-30 | $0.12B | $0.02B | 12.93% |
| 2021-06-30 | $0.10B | $0.01B | 7.92% |
| 2021-03-31 | $0.09B | $0.01B | 8.99% |
| 2020-12-31 | $0.08B | $0.01B | 15.00% |
| 2020-09-30 | $0.07B | $0.01B | 19.12% |
| 2020-06-30 | $0.06B | $0.01B | 23.33% |
| 2020-03-31 | $0.05B | $0.01B | 25.49% |
| 2019-12-31 | $0.05B | $0.01B | 26.67% |
| 2019-09-30 | $0.04B | $0.01B | 27.50% |
| 2019-06-30 | $0.04B | $0.01B | 30.56% |
| 2019-03-31 | $0.03B | $0.01B | 32.35% |
| 2018-12-31 | $0.03B | $0.01B | 34.38% |
| 2018-09-30 | $0.03B | $0.01B | 38.71% |
| 2018-06-30 | $0.03B | $0.01B | 40.00% |
| 2018-03-31 | $0.03B | $0.01B | 40.74% |
| 2017-12-31 | $0.02B | $0.01B | 39.13% |
| 2017-09-30 | $0.02B | $0.01B | 33.33% |
| 2017-06-30 | $0.02B | $0.00B | 26.67% |
| 2017-03-31 | $0.01B | $0.00B | 15.38% |
| 2016-12-31 | $0.01B | $0.00B | 15.38% |
| 2016-09-30 | $0.01B | 0 | 0.00% |
| 2016-06-30 | $0.01B | $0.00B | -8.33% |
| 2016-03-31 | $0.01B | $0.00B | -8.33% |
| 2015-12-31 | $0.01B | $0.00B | -16.67% |
| 2015-09-30 | $0.01B | 0 | 0.00% |
| 2015-06-30 | $0.01B | 0 | 0.00% |
| 2015-03-31 | $0.01B | $-0.01B | -50.00% |
| 2014-12-31 | $0.01B | $-0.01B | -50.00% |
| 2014-09-30 | $0.01B | $-0.01B | -81.82% |
| 2014-06-30 | $0.01B | $-0.01B | -83.33% |
| 2014-03-31 | $0.02B | $-0.01B | -43.75% |
| 2013-12-31 | $0.02B | $-0.01B | -28.57% |
| 2013-09-30 | $0.03B | $0.00B | -6.90% |
| 2013-06-30 | $0.03B | 0 | 0.00% |
| 2013-03-31 | $0.04B | $0.00B | 7.69% |
| 2012-12-31 | $0.04B | $0.00B | 10.00% |
| 2012-09-30 | $0.04B | $0.01B | 12.82% |
| 2012-06-30 | $0.04B | $0.01B | 13.16% |
| 2012-03-31 | $0.04B | $0.01B | 13.89% |
| 2011-12-31 | $0.03B | $0.00B | 11.76% |
| 2011-09-30 | $0.03B | $0.00B | 9.68% |
| 2011-06-30 | $0.03B | $0.00B | 10.34% |
| 2011-03-31 | $0.03B | $0.00B | 7.41% |
| 2010-12-31 | $0.03B | $0.00B | 8.00% |
| 2010-09-30 | $0.02B | $0.00B | 8.70% |
| 2010-06-30 | $0.02B | $0.00B | 9.52% |
| 2010-03-31 | $0.02B | $0.00B | 15.79% |
| 2009-12-31 | $0.02B | $0.00B | 22.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.069B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.771B | 27.51 |
| Boston Scientific (BSX) | United States | $153.093B | 38.33 |
| Stryker (SYK) | United States | $149.084B | 31.17 |
| EssilorLuxottica (ESLOY) | France | $130.144B | 0.00 |
| Medtronic (MDT) | Ireland | $114.429B | 16.22 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.231B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.710B | 24.95 |
| ResMed (RMD) | United States | $36.952B | 27.75 |
| GE HealthCare Technologies (GEHC) | United States | $34.062B | 16.17 |
| Agilent Technologies (A) | United States | $32.082B | 20.92 |
| Terumo (TRUMY) | Japan | $24.207B | 31.44 |
| Koninklijke Philips (PHG) | Netherlands | $23.216B | 16.29 |
| Insulet (PODD) | United States | $20.408B | 80.11 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.604B | 11.95 |
| Baxter (BAX) | United States | $14.497B | 10.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.846B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.731B | 23.42 |
| Lantheus Holdings (LNTH) | United States | $5.622B | 14.18 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Prestige Consumer Healthcare (PBH) | United States | $3.714B | 16.59 |
| Haemonetics (HAE) | United States | $3.585B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.358B | 27.90 |
| ICU Medical (ICUI) | United States | $3.113B | 22.96 |
| QuidelOrtho (QDEL) | United States | $1.890B | 13.00 |
| LeMaitre Vascular (LMAT) | United States | $1.858B | 41.53 |
| AtriCure (ATRC) | United States | $1.512B | 0.00 |
| Acuren (TIC) | United States | $1.407B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.245B | 28.00 |
| Phibro Animal Health (PAHC) | United States | $1.239B | 15.83 |
| AdaptHealth (AHCO) | United States | $1.205B | 12.23 |
| Neogen (NEOG) | United States | $1.079B | 13.81 |
| BioLife Solutions (BLFS) | United States | $0.994B | 0.00 |
| InMode (INMD) | Israel | $0.901B | 9.08 |
| Kestra Medical Technologies (KMTS) | United States | $0.836B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.660B | 0.00 |
| Owens & Minor (OMI) | United States | $0.600B | 4.98 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.597B | 0.00 |
| CeriBell (CBLL) | United States | $0.569B | 0.00 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Surmodics (SRDX) | United States | $0.448B | 0.00 |
| SNDL (SNDL) | Canada | $0.397B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Quanterix (QTRX) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cresco Labs (CRLBF) | United States | $0.258B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.83 |
| ZimVie (ZIMV) | United States | $0.246B | 11.19 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.231B | 61.00 |
| Biote (BTMD) | United States | $0.216B | 6.06 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.155B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.25 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.80 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.41 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |